These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 19917924)

  • 1. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?
    Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.
    Gourin CG; Boyce BJ; Williams HT; Herdman AV; Bilodeau PA; Coleman TA
    Laryngoscope; 2009 Nov; 119(11):2150-5. PubMed ID: 19544378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution.
    Santos AB; Cernea CR; Inoue M; Ferraz AR
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planned post-chemoradiation neck dissection: significance of radiation dose.
    Stenson KM; Huo D; Blair E; Cohen EE; Argiris A; Haraf DJ; Vokes EE
    Laryngoscope; 2006 Jan; 116(1):33-6. PubMed ID: 16481805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.
    Goguen LA; Posner MR; Tishler RB; Wirth LJ; Norris CM; Annino DJ; Sullivan CA; Li Y; Haddad RI
    Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):526-31. PubMed ID: 16702569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
    Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
    Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.
    Farrag TY; Lin FR; Cummings CW; Koch WM; Flint PW; Califano JA; Broussard J; Bajaj G; Tufano RP
    Laryngoscope; 2006 Oct; 116(10):1864-6. PubMed ID: 17003711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of PET/CT in determining need for neck dissection after primary chemoradiation for advanced head and neck squamous cell carcinoma.
    Lyford-Pike S; Ha PK; Jacene HA; Saunders JR; Tufano RP
    ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):251-6. PubMed ID: 19776658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of chemotherapy and radiotherapy in sterilizing cervical nodal disease in squamous cell carcinoma of the head and neck.
    Moore MG; Bhattacharyya N
    Laryngoscope; 2005 Apr; 115(4):570-3. PubMed ID: 15805860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
    Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
    McHam SA; Adelstein DJ; Rybicki LA; Lavertu P; Esclamado RM; Wood BG; Strome M; Carroll MA
    Head Neck; 2003 Oct; 25(10):791-8. PubMed ID: 12966502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary?
    Lim YC; Koo BS; Lee JS; Choi EC
    Laryngoscope; 2006 Jul; 116(7):1232-5. PubMed ID: 16826066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
    Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
    Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.